期刊文献+

长链非编码GATS表达干扰质粒构建抑制乳腺癌细胞增殖和侵袭的研究

Inhibitory regulation of human long non-coding RNA GATS on proliferation and invasion of breast cancer cells
下载PDF
导出
摘要 目的探讨长链非编码GATS对乳腺癌细胞增殖和侵袭的影响。方法构建的人LncRNA-GATSsh RNA1-4慢病毒载体转染乳腺癌MDA-MB-231细胞后,qPCR筛选出干扰效率为50.0%和54.0%的sh1组和sh3组,MTT法和Transwell实验分别检测转染后细胞增殖和侵袭能力;流式细胞术检测转染sh1组慢病毒后细胞周期分布及凋亡变化。结果测序证实,LncRNA-GATS的sh RNA寡聚核苷酸序列已被克隆到pLV-GATS载体;转染MDA-MB-231细胞后,与阴性对照组比较,sh1组和sh3组的乳腺癌细胞增殖和侵袭能力均降低(P〈0.01),以sh1组更显著;sh1组细胞周期被阻滞于S期(P〈0.01);细胞凋亡率无明显变化(P〉0.05)。结论 LncRNA-GATS可能下调乳腺癌细胞侵袭力,并通过抑制细胞周期进展降低细胞增殖能力。 Objective To investigate the effect of human long non-coding RNA GATS on proliferation and invasion of breast cancer MDA-MB-231 cells. Methods Four human GATS-lnc RNA-specific oligonucleotide sequences were designed and synthesized previously, then were inserted into the pLV-GATS vector. After infecting the MDAMB-231 cells, transfection efficiencies of GATS-lnc RNA-sh RNA1 and GATS-lnc RNA-sh RNA3 were analyzed and screened by qPCR, which were 50.0% and 54.0% respectively. MTT and Transwell assays were used to detect the proliferation and invasion ability of the transfected cells, respectively. Flow cytometry was used to search the changes of cell cycle distribution and apoptosis of the MDA-MB-231 cells transfected GATS-lnc RNA-sh RNA1 lentiviral vector. Results Compared with the cells transfected with scrambled sh RNA, the proliferation and invasion ability of cells the sh1 group and sh3 group was inhibited, especially t- hose the sh1 group. Flow cytometry showed the sh1 group cell cycle was arrested in S phase, and the cell apoptosis rate had no significant change(P 0.05).Conclusions lnc RNA GATS inhibits the invasion of breast cancer cells, and down regulates the proliferation of tumor cells through arresting cell cycle in S phase.
出处 《中国现代医学杂志》 CAS 北大核心 2016年第8期17-21,共5页 China Journal of Modern Medicine
关键词 LncRNA-GATS shRNA干扰载体 MDA-MB-231细胞 增殖 侵袭 Human lncRNA GATS short hairpin RNA interference vector MDA-MB-231 cells proliferation invasion
  • 相关文献

参考文献20

  • 1Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-ex- press E-cadherin during mesenchymal to epithelial reverting transition[J]. Mol Cancer, 2010, 9(7): 179.
  • 2Hou G, Zhang S, Zhang X, et al. Clinical pathological character- istics and prognostic analysis of 1013 breast cancer patients with diabetes[l]. Breast Cancer Res Treat, 2013, 137(3): 807-816.
  • 3Hassan MS, Ansari J, Spooner D, et al. Chemotherapy for breast cancer (Review). Oncol Rep, 2010, 24(5): 1121-1131.
  • 4Beg S, Siraj AK, Prabhakaran S, et al. Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer[J]. Breast Cancer Res Treat, 2015, 151(3): 541-553.
  • 5Di GF, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world[J]. Oncotarget, 2014, 305(22): 10976- 10996.
  • 6Liu Y, Zhao J, Zhang W, et al. LncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer[J]. Sci Rep, 2015, 5(11): 10159.
  • 7Kiren YU, Mark RP, Gwyn T. Williams. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells[J]. The Prostate, 2015, 75(7): 693-705.
  • 8Dang S, Qu X, Li W, et al. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression[J]. Hematol Oncol, 2015, 8: 43.
  • 9Sun M, Liu XH, Wang KM, et al. Downregnlation of BRAF ac- tivated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition[J]. Mol Cancer, 2014, 13(1): 68.
  • 10Sun T, Ye HH, Wu CL, et al. Emerging players in prostate cancer: long non-coding RNAs[J]. Am J Clin Exp Urol, 2014, 2(4): 294-299.

二级参考文献8

  • 1Zhang L, Wang JN, Tang JM, et al. VEGF is essential for the growth and migration of human hepatocellular carcinoma cells [J]. Mol Biol Rep, 2012,39(5 ):5085-5093.
  • 2Zhou S, Tan C, Dai Z, et al. Tacrolimus Enhances the Invasion Po- tential of Hepatocellular Carcinoma Cells and Promotes Lymphatic Metastasis in a Rat Model of Hepatocellular Carcinoma: Involvcment of Vascular Endothelial Growth Factor-C [J]. Transplantation Pro- ceedings, 2011,43 (7):2747-2754.
  • 3lnoue K, Torimura T, Nakamura T, et al. Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice[J]. Clin Cancer Res, 2012,18( 14):3924-3933.
  • 4Hammond SM, Bernstein E, Beach D. An RNA-directed mwlease mediates post-transeriptional gene silencing in Drosophila cells[J]. Nature, 2000,404:293-296.
  • 5Thijn R, Brummelkamp, Rene Bernards, et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Ceils [J]. Sci- ence, 2002,296 (5567):550-553.
  • 6Pushparaj PN, Aarthi JJ, Manikandan J, et al. siRNA, miRNA, and shRNA: in vivo applications[J]. J Dent Res, 2008,87:992-1003.
  • 7Heilbronn R, Weger S, Viral vectors for gene transfer: current status of gene therapeutics[J]. Handb Exp Pharmacol, 2010,( 197 ): 143-170.
  • 8Qiu JF, Zhang ZQ, Wang Y, et al. Lentivins-mediated RNAi knockdown of VEGFA in RKO colorectal cancer cells decreases tu- mor formation and growth in vitro and in vivo [J]. Int J Clin Exp Pathol, 2012,5 (4) :290-298.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部